ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander Sells 1,962 Shares of Stock

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander sold 1,962 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $169.08, for a total value of $331,734.96. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

ICU Medical Trading Down 6.0 %

Shares of NASDAQ:ICUI opened at $157.75 on Wednesday. The firm has a 50 day simple moving average of $175.98 and a 200-day simple moving average of $146.15. ICU Medical, Inc. has a twelve month low of $83.26 and a twelve month high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

Analyst Upgrades and Downgrades

ICUI has been the subject of a number of research analyst reports. Jefferies Financial Group initiated coverage on ICU Medical in a report on Monday, October 14th. They set a “hold” rating and a $183.00 price target for the company. Raymond James lifted their price target on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Finally, KeyCorp raised their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, ICU Medical presently has an average rating of “Moderate Buy” and a consensus price target of $173.00.

Hedge Funds Weigh In On ICU Medical

Several large investors have recently bought and sold shares of the stock. Innealta Capital LLC acquired a new stake in shares of ICU Medical during the second quarter worth about $32,000. Hexagon Capital Partners LLC grew its stake in ICU Medical by 162.7% during the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 122 shares during the last quarter. Allworth Financial LP increased its position in ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 100 shares during the period. EntryPoint Capital LLC lifted its stake in ICU Medical by 731.5% in the first quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier’s stock valued at $48,000 after buying an additional 395 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its holdings in shares of ICU Medical by 46.4% in the first quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock valued at $59,000 after acquiring an additional 173 shares during the period. Institutional investors and hedge funds own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.